Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: A prospective study in 412 subjects

Nephrology Dialysis Transplantation

Volumn 12, Issue 12, 1997, Pages 2603-2611

  Koch, Michael ^a   Kutkuhn, Bernd ^a   Grabensee, Bernd ^a   Ritz, Eberhard ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular risk factors; Chronic ambulatory peritoneal dialysis; Diabetes; End stage renal failure; Haemodialysis; Survival; Vascular diseases

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AMPUTATION; ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CLAUDICATION; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; FEMALE; GERMANY; HEART BEAT; HEART INFARCTION; HEART INNERVATION; HEMODIALYSIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SKINFOLD THICKNESS; STROKE; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030715673     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.12.2603     Document Type: Article

References (72)

1. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28: 1039-1057
2. WHO Expert Committee on Diabetes mellitus. World Health Organisation Technical Report Series 640, 1980
3. Degoulet P, Legrain M, Reach I el al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-110
4. Strumpf C, Katz F, Wing AJ, Ritz E. Cardiovascular risk factors and cardiovascular death in haemodialysed diabetic patients. Proc Eur Dial Transplant Assoc Eur Renal Assoc 1985; 21: 202-208
5. Bradley JR, Evans DB, Calne RY. Long-term survival in haemodialysis patients. Lancet 1987; 1(8528): 295-296
6. Held PhJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15(5): 451-457
7. Blagg CR. The US Renal Data System and the Case-Mix Severity Study. Am J Kidney Dis 1993; 21: 106-108
8. Ghavamian M, Gutch CF, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA 1972; 222: 1386-1389
9. Legrain M, Rottembourg J, Bentchikou A et al. Dialysis treatment of insulin dependent diabetic patients: ten years experience. Clin Nephrol 1984; 21: 72-81
10. Koch M, Thomas B, Tschope W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993; 36: 1113-1117
11. Brunner FP, Fassbinder W, Broyer M et al. Survival on renal replacement therapy: data from the EDTA Registry. Nephrol Dial Transplant 1988; 3: 109-122
12. Leehey DJ. Hemodialysis in the diabetic patient with end-stage renal disease. Renal Fail 1994; 16: 547-553
13. Frisancho AR. Triceps skin fold and upper arm muscle size norms for assessment of nutrition status. Am J Clin Nutr 1974; 27: 1052-1058
14. Blumenkrantz MJ, Kopple JD, Gutman RA et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980; 33: 1567-1585
15. Mann J, Ritz E. Arterielle Hypertonie. In: Schettler G, Greton H. (ed). Innere Medizin. Thieme Verlag, Stuttgart, 1990; 159-194
16. Heidbreder E, Schafferhans K, Heidland A. Autonomic neuropathy in chronic renal insufficiency. Comparative analysis of diabetic and nondiabetic patients. Nephron 1985; 41: 50-56
17. Devereux RB. Evaluation of cardiac structure and function by echocardiography and other noninvasive techniques. In Laragh JH, Brenner BM (ed). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press, New York, 1990; 1479-1492
18. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
20. Peto R, Pike MC. Conservatism of the approximation (O-E)2/E in the log rank test for survival data or tumor incidence data. Biometrics 1973; 29: 579-584
21. Cox DR. Regression models and life tables. JR Stat Soc 1972; 34: 187-220
22. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival [Published erratum appears in Am J Kidney Dis 1994 Jul; 24(1):157]. Am J Kidney Dis 1994; 23: 272-282.
23. Krolewski AS, Czyzyk A, Janeczko D, Kopczynski J. Mortality from cardiovascular diseases among diabetics. Diabetologia 1977; 13: 345-350
24. Green A, Borch Johnsen K, Andersen PK et al. Relative mortality of type 1 (insulin-dependent) diabetes in Denmark: 1933-1981. Diabetologia 1985; 28: 339-342
25. Paterson AD, Dornan TL, Peacock I et al. Causes of death in diabetic patients with impaired renal function. An audit of a hospital diabetic clinic population. Lancet 1987; 1(8528): 313-316
26. McMillan MA, Briggs JD, Junor BJ. Outcome of renal replacement treatment in patients with diabetes mellitus. Br Med J 1990; 301: 540-544
27. Koch M, Thomas B, Tschope W, Ritz E. Diabetes mellitus accounts for an ever-increasing proportion of the patients admitted for renal replacement therapy. Nephrol Dial Transplant 1989; 4: 399
28. Raine AEG. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 1993; 36: 1099-1104
29. Biesenbach G, Zazgornik J. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy. Renal Fail 1994; 16: 263-272
30. Benhamou PY, Marwah T, Balducci F et al. Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Nephrol 1992; 38: 239-244
31. Maiorca R, Vonesh EF, Cavalli P et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-127
32. Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992; 3: 1147-1155
33. Hirschl MM, Heinz G, Sunder Plassmann G, Derfler K. Renal replacement therapy in type 2 diabetic patients: 10 years' experience. Am J Kidney Dis 1992; 20: 564-568
34. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993; 21: 113-118
35. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis 1995; 26: 209-219
36. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44: 115-119
37. Tschöpe W, Koch M, Thomas B, Ritz E. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Nephron 1993; 64: 354-358
38. Stephens R, Williams A, McKnight T, Dodd S. Effects of self-monitored exercise on selected blood chemistry parameters of end-stage renal disease patients. Am J Phys Med Rehabil 1991; 70: 149-153
39. Iseki K, Nishime K, Uehara H, Osawa A, Fukiyama K. Effect of renal diseases and comorbid conditions on survival in chronic dialysis patients. Nephron 1994; 68: 80-86
40. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994; 24: 1010-1018
41. Mailloux LU, Bellucci AG, Napolitano B, Mossey T, Wilkes BM, Bluestone PA. Survival estimates for 683 patients starting dialysis from 1970 through 1989: identification of risk factors for survival. Clin Nephrol 1994; 42: 127-135
42. Attman PO, Nyberg G, William Olsson T, Knight Gibson C, Alaupovic P. Dyslipoproteinemia in diabetic renal failure. Kidney Int 1992; 42: 1381-1389
43. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728-736
44. Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1995; 5: 186-191
45. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986; 2: 933-936
46. Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-1430
47. Cremer P, Nagel D, Labrot B et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444-453
48. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23
49. Bostom AG, Gagnon DR, Cupples LA et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90: 1688-1695
50. Yang WS, Kim SB, Min WK, Park S, Lee MS, Park JS. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients. Nephrol Dial Transplant 1995; 10: 1668-1671
51. Wanner C, Bartens W. Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality? (Editorial). Nephrol Dial Transplant 1994; 9: 1066-1068
52. Haffner SM, Moss SE, Klein BE, Klein R. Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 1992; 41: 194-197
53. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475-482
54. Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N. The uremic dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis 1992; 20: 324-335
55. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
56. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996; 27: 1-25
57. Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990;-676
58. Wilhelmsen L, Svardsudd K, Korsan Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
59. Handa K, Kono S, Saku K el al. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis 1989; 77: 209-213
60. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men (Published erratum appears in Arterioscler Thromb 1994 Aug;14(8):1392). Arterioscler Thromb 1994; 14: 54-59
61. Bostom AG, Shemin D, Lapane KL el al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis 1995; 114: 93-103
62. Bartens W, Nauck M, Schollmeyer P, Wanner C. Elevated lipoprotein(a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1996; 16: 27-33
63. Bachmann J, Tepel M, Raidt H et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995; 6: 121-125
64. Krolewski AS. Hypertension associated with diabetes mellitus-past and future (Editorial). J Am Soc Nephrol 1992; 3: 1
65. Braun WE, Phillips DF, Vidt DG et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984; 16: 603-607
66. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: insights from coronary angiography. Kidney Int 1984; 25: 653-659
67. Koch M, Gradaus, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997;
68. Siitonen O, Uusitupa M, Pyorala K, Voutilainen E, Lansimies E. Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics. Acta Med Scand 1986; 220: 205-212
69. Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995; 46: 211-219
70. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 1996; 27: 668-672
71. Rao KV. The influence of preexisting vascular disease on the outcome of renal transplantation in diabetic patients. Nephron 1988; 48: 74-75
72. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75: 894-903